CHD1


Summary: The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in CHD1


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP IEA GO:0006338 chromatin remodeling
BP IEA GO:0006351 transcription, DNA-templated
BP TAS GO:0006357 regulation of transcription by RNA polymerase II
BP IMP GO:0016569 covalent chromatin modification
BP IEA GO:0032508 DNA duplex unwinding
BP IMP GO:0043923 positive regulation by host of viral transcription
Showing 1 to 6 of 16 rows rows per page

Gene expression in normal tissue: CHD1

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in CHD1


Loading, please wait...
Database
Pathway ID
Pathway Des.
wikipathways WP2002 miR-targeted genes in epithelium - TarBase
wikipathways WP2004 miR-targeted genes in lymphocytes - TarBase
wikipathways WP2005 miR-targeted genes in muscle cell - TarBase
reactome R-HSA-162582 Signal Transduction
reactome R-HSA-8939211 ESR-mediated signaling
reactome R-HSA-9006931 Signaling by Nuclear Receptors
Showing 1 to 6 of 7 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD138 PX 12 3
iGMDRD260 FQI-2 2
iGMDRD64 Parbendazole 4
iGMDRD188 Piperlongumine 5
Showing 1 to 4 of 36 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in CHD1

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​